首页> 外文期刊>Cardiovascular Research >SKA-31, a novel activator of SKCa and IKCa channels, increases coronary flow in male and female rat hearts
【24h】

SKA-31, a novel activator of SKCa and IKCa channels, increases coronary flow in male and female rat hearts

机译:SKA-31是SKCa和IKCa通道的新型激活剂,可增加雄性和雌性大鼠心脏中的冠脉流量

获取原文
获取原文并翻译 | 示例
       

摘要

AimsEndothelial SKCa and IKCa channels play an important role in the regulation of vascular function and systemic blood pressure. Based on our previous findings that small molecule activators of SKCa and IKCa channels (i.e. NS309 and SKA-31) can inhibit myogenic tone in isolated resistance arteries, we hypothesized that this class of compounds may induce effective vasodilation in an intact vascular bed, such as the coronary circulation.Methods and resultsIn a Langendorff-perfused, beating rat heart preparation, acute bolus administrations of SKA-31 (0.01-5 μg) dose-dependently increased total coronary flow (25-30%) in both male and female hearts; these responses were associated with modest, secondary increases in left ventricular (LV) systolic pressure and heart rate. SKA-31 evoked responses in coronary flow, LV pressure, and heart rate were qualitatively comparable to acute responses evoked by bradykinin (1 μg) and adenosine (10 μg). In the presence of apamin and TRAM-34, selective blockers of SK Ca and IKCa channels, respectively, SKA-31 and bradykinin-induced responses were largely inhibited, whereas the adenosine-induced changes were blocked by ~40%; TRAM-34 alone produced less inhibition. Sodium nitroprusside (SNP, 0.2 μg bolus dose) evoked changes in coronary flow, LV pressure, and heart rate were similar to those induced by SKA-31, but were unaffected by apamin + TRAM-34. The NOS inhibitor L-NNA reduced bradykinin-and adenosine-evoked changes, but did not affect responses to either SKA-31 or SNP.ConclusionOur study demonstrates that SKA-31 can rapidly and reversibly induce dilation of the coronary circulation in intact functioning hearts under basal flow and contractility conditions.
机译:目的内皮SKCa和IKCa通道在调节血管功能和全身血压中起重要作用。基于我们以前的发现,SKCa和IKCa通道的小分子激活剂(即NS309和SKA-31)可以抑制孤立的阻力动脉中的肌原性紧张,我们假设这类化合物可以在完整的血管床中诱导有效的血管舒张,例如方法和结果在Langendorff灌注的,跳动的大鼠心脏制剂中,急性推注SKA-31(0.01-5μg)剂量依赖性地增加了男性和女性心脏的总冠脉流量(25-30%);这些反应与左心室(LV)收缩压和心率的适度,继发性升高有关。 SKA-31引起的冠状动脉血流量,左室压力和心率反应在质量上与缓激肽(1μg)和腺苷(10μg)引起的急性反应相当。在存在Apapamin和TRAM-34时,SK Ca和IKCa通道的选择性阻滞剂分别显着抑制了SKA-31和缓激肽诱导的反应,而腺苷诱导的变化被抑制了约40%。单独的TRAM-34产生较少的抑制。硝普钠(SNP,0.2μg推注剂量)引起的冠状动脉血流量,左心室压力和心率变化与SKA-31诱导的相似,但不受apamin + TRAM-34的影响。 NOS抑制剂L-NNA减少了缓激肽和腺苷引起的变化,但不影响对SKA-31或SNP的反应。结论我们的研究表明,SKA-31可以快速和可逆地诱导完好的正常心脏下冠状动脉循环扩张基础流量和收缩条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号